KingBOhyamaMKwonO, et al. Two phase 3 trials of baricitinib for alopecia areata. N Engl J Med. 2022;386(18):1687-1699. doi:10.1056/NEJMoa2110343
2.
Moreno-VílchezCBonfill-OrtíMBauer-AlonsoANotarioJFigueras-NartI. Baricitinib for the treatment of alopecia areata in adults: real-world analysis of 36 patients. J Am Acad Dermatol. 2024;90(5):1059-1061. doi:10.1016/j.jaad.2023.09.089
3.
MourtadaADouarecCWargnyM, et al. Real-life effectiveness and safety of baricitinib in adults with alopecia areata: a multicentre study. J Eur Acad Dermatol Venereol. 2025;2025:e0657. doi:10.1111/jdv.20657
4.
PiracciniBMPampaloniFCedirianS, et al. Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: a 24-week Italian study. J Eur Acad Dermatol Venereol. 2025;39(6):1143-1151. doi:10.1111/jdv.20312
5.
KingBShapiroJOhyamaM, et al. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials. Br J Dermatol. 2023;189(6):666-673. doi:10.1093/bjd/ljad253
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
